Selective Targeting of Protein Kinase C (PKC)-θ Nuclear Translocation Reduces Mesenchymal Gene Signatures and Reinvigorates Dysfunctional CD8+ T Cells in Immunotherapy-Resistant and Metastatic Cancers

Citation

Dunn, J, McCuaig, R, Tan, A et al. 2022, 'Selective Targeting of Protein Kinase C (PKC)-θ Nuclear Translocation Reduces Mesenchymal Gene Signatures and Reinvigorates Dysfunctional CD8+ T Cells in Immunotherapy-Resistant and Metastatic Cancers', Cancers, vol. 14, no. 6.

Year

2022

Updated:  01 February 2023 / Responsible Officer:  Director (Research Services Division) / Page Contact:  Researchers